| Dr Daniel Boudaie, DMD | |
|
10933 Victory Blvd, North Hollywood, CA 91606-3717 | |
| (818) 509-1818 | |
| (818) 509-1647 |
| Full Name | Dr Daniel Boudaie |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 10933 Victory Blvd, North Hollywood, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033210489 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 30633 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Boudaie, DMD 10933 Victory Blvd, North Hollywood, CA 91606-3717 Ph: (818) 509-1818 | Dr Daniel Boudaie, DMD 10933 Victory Blvd, North Hollywood, CA 91606-3717 Ph: (818) 509-1818 |
News Archive
Next week NPS will host its inaugural webinar for GPs looking at medical imaging in respiratory tract infections (RTIs). Forming part of the NPS campaign on antibiotic resistance, the webinar on 10 May enables GPs to engage with imaging experts in real-time and gain insights into when imaging is appropriate for RTIs.
The co-authors are employees of the Protein-Cell Interactions Lab of Kazan Federal University (Natalia G. Evtugina, Alina D. Peshkova, and Lab Head Rustem I. Litvinov) in cooperation with Interregional Clinical Diagnostic Center, Kazan, Russia (Arseniy A. Pichugin) and University of Pennsylvania (John W. Weisel and Rustem I. Litvinov by his primary employment).
Octapharma USA has received confirmation of orphan drug exclusivity from the U.S. Food and Drug Administration for wilate (von Willebrand Factor/Factor VIII Concentrate, Human), the replacement therapy developed specifically for von Willebrand Disease. The approval comes from the FDA Office of Orphan Products Development, which helps to advance the development of products that demonstrate promise for the treatment of rare diseases.
A multi-institutional study has identified a potential personalized treatment target for the most common form of ovarian cancer. In the December 8 issue of Cancer Cell, the research team describes finding that a gene called MAGP2 - not previously associated with any type of cancer - was overexpressed in papillary serous ovarian tumors of patients who died more quickly. They also found evidence suggesting possible mechanisms by which MAGP2 may promote tumor growth.
› Verified 9 days ago
Julieta Sanchez Martinez, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 12120 Saticoy St Ste C, North Hollywood, CA 91605 Phone: 818-255-2244 | |
Dr. Dorina Popescu, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 12932 Victory Blvd, North Hollywood, CA 91606 Phone: 818-761-9000 Fax: 818-761-6067 | |
Dr. Dora Elida Arango, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 7554 Laurel Canyon Blvd, North Hollywood, CA 91605 Phone: 818-982-0294 Fax: 818-982-1527 | |
Dr. Roland Yakubov, DMD Dentist Medicare: Medicare Enrolled Practice Location: 6428 Bellingham Ave, North Hollywood, CA 91606 Phone: 818-985-1407 | |
Hector Meza-lopez, Dentist Medicare: Not Enrolled in Medicare Practice Location: 12902 Victory Blvd, North Hollywood, CA 91606 Phone: 818-284-6440 | |
Lawrence Lee, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 6801 Coldwater Canyon Ave, North Hollywood, CA 91605 Phone: 917-304-1712 |